Latest research supports Mediterranean and Asian-style eating plans to reduce risk of AMD
Read moreBy The Hon. Jillian Skinner, AM, former NSW Minister for Health.This article was originally published by News Corp.
Welcome to our final Vision Voice newsletter for the year.
MDFA has received a positive response from the people participating in our new Eye Connect support service.
Macular Disease Foundation Australia (MDFA) has launched its new Research Impact Report, which showcases the groundbreaking projects our organisation has funded to help reduce the impact of macular disease.
The Federal Government has announced that from 1 July 2025, people receiving sight-saving eye (intravitreal) injections to treat macular disease will no longer receive health fund benefits for this treatment if it is performed in private hospitals and day surgeries.
Dilini is one of MDFA’s Health Promotion Officers supporting people with age-related macular degeneration through our new Eye Connect service. A qualified Vision Scientist and training Optometrist, let’s find out more about Dilini and her experiences helping people with macular disease, Australia’s leading cause of blindness.
Welcome to the Spring 2024 edition of Vision Voice.
MDFA is pleased to announce that NSW government’s former Minister for Health and Minister for Medical research, the Hon. Jillian Skinner AM, has joined as our newest Ambassador.
In our latest edition of Vision Voice, Shane candidly shares his experience of managing vision loss while still working, as well as maintaining a positive and busy life after his career.
Comedian Bron Lewis stars in new MDFA community service video
It’s all very painless really. And your eyes might be grateful.
New findings reveal that consuming more than 12g of alcohol per day (less than one large glass of wine or large beer) is linked to a higher risk of developing irreversible vision loss; new nutrition guidelines released to help protect Australians’ eyesight.
Macular Disease Foundation Australia (MDFA) has welcomed the Federal Government’s decision to defer the private health insurance reclassification of intravitreal (eye) injections from 1 July 2025 to 1 July 2026 and undertake further consultation.
We have released new research in collaboration with the University of New South Wales which has revealed the median total cost for people living with macular disease, who also receive sight-saving eye injections, is 12 percent* ($3,621) of the annual government pension payment.
By The Hon. Jillian Skinner, AM, former NSW Minister for Health.This article was originally published by News Corp.
Macular Disease Foundation Australia calls on the next Federal Government to bulk-bill sight-saving eye injections for pensioners; with the potential for creating a $140 million cost-saving per year.
The Therapeutic Goods Administration (TGA) approval of the new eye injection treatment SYFOVRE® (pegcetacoplan) is welcome news, as it will give many people with Geographic Atrophy a treatment option that they’ve never had before to slow the progression of the disease.
Welcome to our final Vision Voice newsletter for the year.
MDFA has received a positive response from the people participating in our new Eye Connect support service.
Macular Disease Foundation Australia (MDFA) has launched its new Research Impact Report, which showcases the groundbreaking projects our organisation has funded to help reduce the impact of macular disease.
The Federal Government has announced that from 1 July 2025, people receiving sight-saving eye (intravitreal) injections to treat macular disease will no longer receive health fund benefits for this treatment if it is performed in private hospitals and day surgeries.
We aim to respond to your request by the next business day. If you require assistance sooner, please call our National Helpline on 1800 111 709 (Monday - Friday 9-5pm AEST).
If your query is about an eye emergency - including sudden changes to your vision or eye pain - please contact your optometrist or ophthalmologist as soon as possible.
Great!